產(chǎn)品名稱 ML314
產(chǎn)品貨號 Axon 2632 CAS [1448895-09-7] MF C24H28N4O3MW 420.50 Purity: 100% Soluble in 0.1N HCl(aq) and DMSO Description Brain penetrant nonpeptidic β-Arrestin biased full agonist of the neurotensin NTR1 receptor (EC50 values 2.0 μM and >80 μM for NTR1 and NTR2, respectively). Unlike peptide-based NTR1 agonists, ML314 has no significant response in a Ca2+ mobilization assay. ML314 is a viable, preclinical lead for methamphetamine abuse treatment. KEYWORDS:?ML314 | supplier | NTR1 agonist | ML-314 | CAS [1448895-09-7] | Neurotensin | GPCR | drug abuse | allosteric | β-arrestin | dopamine | CNS | BBB
產(chǎn)品價格 現(xiàn)貨詢價,電話:010-67529703
產(chǎn)品規(guī)格
產(chǎn)品品牌 axonmedchem
產(chǎn)品概述
產(chǎn)品詳情

ML314

Based on 16 reference(s) in Google Scholar 9 10 16

Axon 2632

CAS [1448895-09-7]

MF C24H28N4O3
MW 420.50

  • Purity: 100%
  • Soluble in 0.1N HCl(aq) and DMSO

ML314

Description

Brain penetrant nonpeptidic β-Arrestin biased full agonist of the neurotensin NTR1 receptor (EC50 values 2.0 μM and >80 μM for NTR1 and NTR2, respectively). Unlike peptide-based NTR1 agonists, ML314 has no significant response in a Ca2+ mobilization assay. ML314 is a viable, preclinical lead for methamphetamine abuse treatment.

KEYWORDS:?ML314 | supplier | NTR1 agonist | ML-314 | CAS [1448895-09-7] | Neurotensin | GPCR | drug abuse | allosteric | β-arrestin | dopamine | CNS | BBB

產(chǎn)品資料